Top

Breast Cancer Research and Treatment

Published in:

01-12-2020 | Breast Cancer | Letter to the Editor

Letter to the editor with regard to the manuscript titled “Circulating tumour cell enumeration does not correlate with Miller–Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy”

Authors: Rui Chen, Ge Ma, Tiansong Xia

Published in: Breast Cancer Research and Treatment | Issue 3/2020

Excerpt

To the editor, …

O’Toole SA, Spillane C, Huang Y et al (2020) Circulating tumour cell enumeration does not correlate with Miller-Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy. Breast Cancer Res Treat 181(3):571–580. https://doi.org/10.1007/s10549-020-05658-7CrossRefPubMedPubMedCentral

Ma G, Wang J, Liu X et al (2019) Prediction of neoadjuvant chemotherapeutic efficacy by CTC and cfDNA in patients with locally advanced breast cancer. J Clin Oncol 37:551–551. https://doi.org/10.1200/JCO.2019.37.15_suppl.551CrossRef

Ma G, Jiang Y, Liang M et al (2020) Dynamic monitoring of CD45-/CD31+/DAPI+ circulating endothelial cells aneuploid for chromosome 8 during neoadjuvant chemotherapy in locally advanced breast cancer. Ther Adv Med Oncol 12:1–14. https://doi.org/10.1177/1758835920918470CrossRef

Title: Letter to the editor with regard to the manuscript titled “Circulating tumour cell enumeration does not correlate with Miller–Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy”
Authors: Rui Chen
Ge Ma
Tiansong Xia
Publication date: 01-12-2020
Publisher: Springer US
Keywords: Breast Cancer
Breast Cancer
Cytostatic Therapy
Published in: Breast Cancer Research and Treatment / Issue 3/2020
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-020-05886-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2020

Diffuse tensor imaging of lower extremities: a novel MR imaging technique for chemotherapy-induced peripheral neuropathy

Predicting adjuvant endocrine therapy initiation and adherence among older women with early-stage breast cancer

Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia

Bone-protective and anti-tumor effect of baicalin in osteotropic breast cancer via induction of apoptosis

Assessment of stromal tumor infiltrating lymphocytes and immunohistochemical features in invasive micropapillary breast carcinoma with long-term outcomes

Language impairment among patients with different types of cancer. Comparison with healthy adults

Keynote webinar | Spotlight on antibody–drug conjugates in cancer